Cargando…

Systemic but No Local Effects of Combined Zoledronate and Parathyroid Hormone Treatment in Experimental Autoimmune Arthritis

INTRODUCTION: Local bone erosions and osteoporosis in rheumatoid arthritis (RA) are the result of a more pronounced bone resorption than bone formation. Present treatment strategies for RA inhibit inflammation, but do not directly target bone erosions. The aim of the study was in experimental arthri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keller, Kresten Krarup, Thomsen, Jesper Skovhus, Stengaard-Pedersen, Kristian, Hauge, Ellen-Margrethe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956918/ https://www.ncbi.nlm.nih.gov/pubmed/24637846 http://dx.doi.org/10.1371/journal.pone.0092359

Ejemplares similares

Bone Formation and Resorption Are Both Increased in Experimental Autoimmune Arthritis
por: Keller, Kresten Krarup, et al.
Publicado: (2012)

Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response
por: Kragstrup, Tue Wenzel, et al.
Publicado: (2016)

Histomorphometric case-control study of subarticular osteophytes in patients with osteoarthritis of the hip
por: Klose-Jensen, Rasmus, et al.
Publicado: (2020)

The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings
por: Greisen, Stinne R., et al.
Publicado: (2022)

Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss
por: Brent, Mikkel Bo, et al.
Publicado: (2022)

Parathyroid hormone PTH(1–34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits
por: Aleksyniene, Ramune, et al.
Publicado: (2009)

Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice
por: Vegger, Jens Bay, et al.
Publicado: (2018)

Smartphone Pedometer Sensor Application for Evaluating Disease Activity and Predicting Comorbidities in Patients with Rheumatoid Arthritis: A Validation Study
por: Wagner, Stefan R., et al.
Publicado: (2022)

Programmed death ligand 2 – A link between inflammation and bone loss in rheumatoid arthritis
por: Greisen, Stinne R., et al.
Publicado: (2019)

Thickness of the bone-cartilage unit in relation to osteoarthritis severity in the human hip joint
por: Hartlev, Louise Brøndt, et al.
Publicado: (2018)

Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis
por: Pedersen, Janni Maria, et al.
Publicado: (2023)

High-Resolution Peripheral Quantitative Computed Tomography for Bone Evaluation in Inflammatory Rheumatic Disease
por: Klose-Jensen, Rasmus, et al.
Publicado: (2020)

Methotrexate utilization in Rheumatoid arthritis. A register-based cohort-study of treatment re-starts after gabs of at least 90 days
por: de Thurah, Annette, et al.
Publicado: (2015)

Mitral valvulitis as a severe extra-articular manifestation of rheumatoid arthritis: a case report
por: Frederiksen, Anne Sofie, et al.
Publicado: (2021)

Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
por: Kimura, Shigemi, et al.
Publicado: (2014)

Tissue Parathyroid Hormone Washout: A Reliable Method for the Localization and Exclusion of Parathyroid Adenomas
por: Güneş, Elif, et al.
Publicado: (2023)

National differences in vaccine hesitancy: a concern for the external validity of vaccine studies
por: Ammitzbøll, Christian, et al.
Publicado: (2021)

The Parathyroid Hormone-Related Protein/Parathyroid Hormone 1 Receptor Axis in Adipose Tissue
por: Izquierdo-Lahuerta, Adriana
Publicado: (2021)

Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis
por: Zhao, Yawei, et al.
Publicado: (2023)

Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
por: Schneider, Jenny Sarah, et al.
Publicado: (2017)

Additive Effect of Parathyroid Hormone and Zoledronate Acid on Prevention Particle Wears-Induced Implant Loosening by Promoting Periprosthetic Bone Architecture and Strength in an Ovariectomized Rat Model
por: Zhou, Chenhe, et al.
Publicado: (2022)

Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry
por: Linauskas, Asta, et al.
Publicado: (2018)

Inhibition of Parathyroid Hormone Secretion by Caffeine in Human Parathyroid Cells
por: Lu, Ming, et al.
Publicado: (2013)

Behavioural actions of tuberoinfundibular peptide 39 (parathyroid hormone 2)
por: Keller, Dávid, et al.
Publicado: (2022)

Parathyroid hormone and vitamin D.
por: Harrison, H. E.
Publicado: (1966)

Parathyroid Hormone Signaling in Osteocytes
por: Wein, Marc N
Publicado: (2017)

The effectiveness of e-learning in patient education delivered to patients with rheumatoid arthritis: The WebRA study—protocol for a pragmatic randomised controlled trial
por: Raunsbæk Knudsen, Line, et al.
Publicado: (2021)

Strontium doping of bone graft extender: Effect on fixation of allografted experimental implants
por: Vestermark, Marianne T, et al.
Publicado: (2011)

Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation
por: Osagie-Clouard, L., et al.
Publicado: (2017)

Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder
por: Turan, Serap
Publicado: (2017)

Combination Therapy with Zoledronic Acid and Parathyroid Hormone Improves Bone Architecture and Strength following a Clinically-Relevant Dose of Stereotactic Radiation Therapy for the Local Treatment of Canine Osteosarcoma in Athymic Rats
por: Curtis, Ryan C., et al.
Publicado: (2016)

The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice
por: Brent, Mikkel Bo, et al.
Publicado: (2017)

The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar
por: Brent, Mikkel Bo, et al.
Publicado: (2020)

Animal models of disuse-induced bone loss: study protocol for a systematic review
por: Brent, Mikkel Bo, et al.
Publicado: (2020)

Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice
por: Brent, Mikkel Bo, et al.
Publicado: (2021)

Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis
por: Bartels, Lars Erik, et al.
Publicado: (2021)

Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study
por: Kuroda, Tatsuhiko, et al.
Publicado: (2021)

IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA
por: Tashjian, Armen H., et al.
Publicado: (1964)

Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
por: Allen, Miya E., et al.
Publicado: (2013)

Atypical parathyroid tumor: clinical and parathyroid hormone response to surgical treatment
por: Napolitano, Antonio Giulio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f5sjkjbauvorhmislcs8ku3g4j